{
  "ticker": "FDMT",
  "success": true,
  "price": {
    "current": 8.97,
    "currency": "USD",
    "day_high": 9.1,
    "day_low": 8.3,
    "52_week_high": 12.34,
    "52_week_low": 2.235
  },
  "market_cap": {
    "value": 512501632.0,
    "currency": "USD"
  },
  "shares_outstanding": 51007874.0,
  "volume": {
    "last": 591078,
    "average_30d": 754022
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -2.5787423,
    "price_to_book": 1.1370263
  },
  "company_info": {
    "name": "4D Molecular Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 423982000.0,
    "total_liabilities": 54999000.0,
    "stockholders_equity": 368983000.0,
    "cash": 48555000.0,
    "marketable_securities": 256508000.0,
    "total_liquidity": 305063000.0,
    "total_debt": 22263000.0,
    "long_term_debt": 16568000.0,
    "current_debt": 5695000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:31:47.422648",
    "url": "https://finance.yahoo.com/quote/FDMT",
    "data_hash": "d414e13837be5ff9"
  }
}